Evidence map›Paper›PMID 34686350›Full record

ArticleCell reports2021

ADAR1 restricts ZBP1-mediated immune response and PANoptosis to promote tumorigenesis.

Rajendra Karki, Balamurugan Sundaram, Bhesh Raj Sharma, SangJoon Lee, R K Subbarao Malireddi, Lam Nhat Nguyen, Shelbi Christgen, Min Zheng, Yaqiu Wang, Parimal Samir and 3 more

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 301 papers.

0numbers the graph read from it
0cells of the map it votes in
301citing papers in PubMed
19.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

301 citing papers in PubMed, 372 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Mechanisms, regulation and clinical relevance of necroptosis.Nature reviews. Molecular cell biology · 2026
    Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. TSG FromFood science & nutrition · 2026
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Targeting the non-coding RNA-PANoptosis axis: a novel frontier in disease diagnosis and therapy.Apoptosis : an international journal on programmed cell death · 2026
    Review
  16. PANoptosis and Immune Remodeling in the Tumor Microenvironment.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Review
  17. Review
  18. Review
  19. Article
  20. Review

241 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Rajendra KarkiDepartment of Immunology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Balamurugan SundaramDepartment of Immunology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Bhesh Raj SharmaDepartment of Immunology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
SangJoon LeeDepartment of Immunology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
R K Subbarao MalireddiDepartment of Immunology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Lam Nhat NguyenDepartment of Immunology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Shelbi ChristgenDepartment of Immunology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Min ZhengDepartment of Immunology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Yaqiu WangDepartment of Immunology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Parimal SamirDepartment of Immunology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Geoffrey NealeHartwell Center for Bioinformatics & Biotechnology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Peter VogelAnimal Resources Center and Veterinary Pathology Core, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Thirumala-Devi KannegantiDepartment of Immunology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA. Electronic address: thirumala-devi.kanneganti@stjude.org.
St. Jude Children's Research Hospital · US

Funding

Innate immune sensors, inflammasomes, and inflammasome-mediated processes in cancerR35CA253095 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI Thirumala-Devi Kanneganti · 2020 to 2026
$7.0M
Role of NLR Inflammasomes in Autoinflammatory Diseases and Host DefenseR01AR056296 · NIAMS · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI KANNEGANTI, THIRUMALA-DEVI · 2008 to 2022
$5.9M
The Non-Inflammasome NLRs in Immunity and Host defenseR01AI124346 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI Thirumala-Devi Kanneganti · 2016 to 2026
$5.8M
Inflammatory Caspases in Innate Immunity and InflammationR37AI101935 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI Thirumala-Devi Kanneganti · 2017 to 2026
$4.9M
Targeting innate immune pathways, and inflammatory cell death in cytokine-mediated diseasesR01AI160179 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI KANNEGANTI, THIRUMALA-DEVI · 2021 to 2025
$4.2M
Inflammatory Caspases in Innate Immunity and InflammationR01AI101935 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI KANNEGANTI, THIRUMALA-DEVI · 2012 to 2016
$2.2M
NCI NIH HHS R35 CA253095NIAID NIH HHS R01 AI101935NIAID NIH HHS R01 AI124346NIAID NIH HHS R01 AI160179NIAID NIH HHS R37 AI101935NIAMS NIH HHS R01 AR056296
6 · The paper itself

Abstract

Cell death provides host defense and maintains homeostasis. Zα-containing molecules are essential for these processes. Z-DNA binding protein 1 (ZBP1) activates inflammatory cell death, PANoptosis, whereas adenosine deaminase acting on RNA 1 (ADAR1) serves as an RNA editor to maintain homeostasis. Here, we identify and characterize ADAR1's interaction with ZBP1, defining its role in cell death regulation and tumorigenesis. Combining interferons (IFNs) and nuclear export inhibitors (NEIs) activates ZBP1-dependent PANoptosis. ADAR1 suppresses this PANoptosis by interacting with the Zα2 domain of ZBP1 to limit ZBP1 and RIPK3 interactions. Adar1

Indexed as

Adenosine DeaminaseAnimalsAntineoplastic Combined Chemotherapy ProtocolsCell DeathCell Transformation, NeoplasticColorectal NeoplasmsFemaleGene Expression Regulation, NeoplasticHEK293 CellsHumansHydrazinesInterferon-gammaMaleMelanoma, ExperimentalMiceMice, Inbred C57BLADAR1 protein, mouseAdenosine DeaminaseHydrazinesInterferon-gammaReceptor-Interacting Protein Serine-Threonine KinasesRipk3 protein, mouseRNA-Binding ProteinsselinexorTriazolesZbp1 protein, mouseADAR1apoptosisIFNinflammasomenecroptosisPANoptosisPANoptosomepyroptosistumorigenesisZBP1

Identifiers

PMID34686350
PMCPMC8853634
OpenAlexW3206448302

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.